Analysis of inherited genetic variations at the UGT1 locus in the French‐Canadian population

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Human Mutation

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/humu.20946PMID 19204906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linkage Disequilibrium

  2010cited by this paper
• Genetic Variations and Haplotypes of UDP-glucuronosyltransferase 1A Locus in a Korean Population

  2008cited by this paper
• Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients

  2008cited by this paper
• Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk

  2008cited by this paper
• Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity

  2007cited by this paper
• A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3

  2007cited by this paper
• Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer

  2007cited by this paper
• The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

  2007cited by this paper
• UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

  2007cited by this paper
• Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes

  2007cited by this paper
• UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of Women

  2007cited by this paper
• Regulation of the UGT1A1 bilirubin‐conjugating pathway: Role of a new splicing event at the UGT1A locus

  2007cited by this paper
• Comparative genomics analysis of human sequence variation in the UGT1A gene cluster

  2006cited by this paper
• Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus

  2006cited by this paper
• THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER

  2006cited by this paper
• Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer

  2006cited by this paper
• Influence of Nonsynonymous Polymorphisms of UGT1A8 and UGT2B7 Metabolizing Enzymes on the Formation of Phenolic and Acyl Glucuronides of Mycophenolic Acid

  2006cited by this paper
• Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.

  2006cited by this paper
• Haplotype structures of the UGT1A gene complex in a Japanese population

  2006cited by this paper
• Navigating the HapMap

  2006cited by this paper
• Gilbert's disease and atazanavir: From phenotype to UDP‐glucuronosyltransferase haplotype

  2006cited by this paper
• UDP-GLUCURONOSYLTRANSFERASE 1A4 POLYMORPHISMS IN A JAPANESE POPULATION AND KINETICS OF CLOZAPINE GLUCURONIDATION

  2005cited by this paper
• Linkage disequilibrium patterns vary substantially among populations

  2005cited by this paper
• Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.

  2005cited by this paper
• Spectrum of UGT1A1 mutations in Crigler‐Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype‐phenotype correlation

  2005cited by this paper
• UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families.

  2005cited by this paper
• Linkage disequilibrium across the UGT1A locus should not be ignored in association studies of cancer susceptibility.

  2005cited by this paper
• The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

  2005cited by this paper
• Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.

  2005cited by this paper
• UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: II. Functional Impact of the Three Most Common Nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S)

  2005cited by this paper
• UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

  2005cited by this paper
• A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity.

  2004cited by this paper
• Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

  2004cited by this paper
• Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP‐glucuronosyltransferase UGT1A4

  2004cited by this paper
• Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.

  2004cited by this paper
• The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk

  2004cited by this paper
• Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.

  2004cited by this paper
• Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells.

  2004cited by this paper
• Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity

  2004cited by this paper
• Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

  2004cited by this paper
• Novel Functional Polymorphisms in the UGT1A7 and UGT1A9 Glucuronidating Enzymes in Caucasian and African-American Subjects and Their Impact on the Metabolism of 7-Ethyl-10-hydroxycamptothecin and Flavopiridol Anticancer Drugs

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.

  2003cited by this paper
• Pharmacogenomics of human UDP-glucuronosyltransferase enzymes

  2003cited by this paper
• Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome.

  2003cited by this paper
• Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.

  2003cited by this paper
• Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3.

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer

  2002cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

  2001cited by this paper
• Extent and distribution of linkage disequilibrium in three genomic regions.

  2001cited by this paper
• Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.

  2001cited by this paper
• Association Between Uncoupling Protein 3 Gene and Obesity-Related Phenotypes in the Québec Family Study

  2001cited by this paper
• Metabolic gene polymorphism frequencies in control populations.

  2001cited by this paper
• Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion.

  2001cited by this paper
• Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.

  2000cited by this paper
• Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.

  2000cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Phenotype‐genotype correlation of in vitro SN‐38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

  1999cited by this paper
• UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan.

  1998cited by this paper
• Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.

  1997cited by this paper
• The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

  1995cited by this paper
• A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.

  1992cited by this paper
• Mechanisms of inherited deficiencies of multiple UDP‐glucuronosyltransferase isoforms in two patients with Crigler‐Najjar syndrome, type I

  1992cited by this paper
• UDP-glucuronosyltransferases.

  1989cited by this paper
• UDP-glucur-onosyltransferases

  1989cited by this paper

• Impact of UGT1A4 Polymorphisms on the Posaconazole Serum Trough Concentrations in Patients with Acute Myeloid Leukemia Receiving Delayed-Release Tablets.

  2025cites this paper
• UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure

  2024cites this paper
• Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma

  2023cites this paper
• Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes

  2021cites this paper
• Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine

  2016influential citation
• Direct measurement of Bisphenol A (BPA), BPA glucuronide and BPA sulfate in a diverse and low-income population of pregnant women reveals high exposure, with potential implications for previous exposure estimates: a cross-sectional study

  2016cites this paper
• Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.

  2015cites this paper
• The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.

  2015cites this paper
• Personalisation of therapy in advanced colorectal cancer

  2015influential citation
• Pharmacogenomics of Human Uridine Diphospho‐Glucuronosyltransferases and Clinical Implications

  2014cites this paper
• Characterization of the Zebrafish Ugt Repertoire Reveals a New Class of Drug-Metabolizing UDP Glucuronosyltransferases

  2014cites this paper
• Microsoft Word-15240917-file00.docx

  2014cites this paper
• Refining the UGT1A Haplotype Associated with Irinotecan-Induced Hematological Toxicity in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Irinotecan-Based Regimens

  2013cites this paper
• The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure

  2013cites this paper
• Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics

  2013cites this paper
• Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations

  2013influential citation
• Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

  2013cites this paper
• Refining the UGT 1 A Haplotype Associated with Irinotecan-Induced Hematological Toxicity in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil / Irinotecan-Based Regimens s

  2013cites this paper
• UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population

  2012cites this paper
• Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation

  2012cites this paper
• Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

  2012cites this paper
• Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry.

  2012cites this paper
• Population pharmacokinetics and pharmacogenetics of antiretroviral drugs

  2012cites this paper
• Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients

  2012cites this paper
• Population Pharmacokinetic Analysis and Pharmacogenetics

  2012cites this paper
• Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals

  2012cites this paper
• Genetic Variations and Haplotype Diversity of the UGT1 Gene Cluster in the Chinese Population

  2012influential citation
• Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer.

  2011cites this paper
• Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations

  2011cites this paper
• Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine

  2011cites this paper
• UDP‐Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

  2010cites this paper
• UDP-Glucuronosyltransferase 1A1 and the Glucuronidation in Oncology Applications and Hyperbilirubinemia

  2010cites this paper
• In vitro glucuronidation of fenofibric acid by human UGTs and liver microsomes.

  2009influential citation
• A pharmacogenetics study of the human glucuronosyltransferase UGT1A4

  2009cites this paper
• In Vitro Glucuronidation of Fenofibric Acid by Human UDP-Glucuronosyltransferases and Liver Microsomes

  2009cites this paper
• Pharmacogenetics‐Based Population Pharmacokinetic Analysis of Efavirenz in HIV‐1‐Infected Individuals

  2009cites this paper
• Method for determining the predisposition of a subject to altered biotransformation and the development of adverse reactions in treatment of the patient with atorvastatin

  2009cites this paper